Bone Biologics Corp Stock Technical Analysis
| BBLG Stock | USD 1.22 0.04 3.17% |
As of the 1st of December, Bone Biologics shows the Risk Adjusted Performance of 0.0489, downside deviation of 9.6, and Mean Deviation of 9.09. Bone Biologics Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bone Biologics Corp downside variance, skewness, as well as the relationship between the maximum drawdown and information ratio to decide if Bone Biologics Corp is priced correctly, providing market reflects its regular price of 1.22 per share. Given that Bone Biologics is a hitting penny stock territory we recommend to closely look at its total risk alpha.
Bone Biologics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Bone, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BoneBone |
Bone Biologics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 37.75 | Strong Buy | 1 | Odds |
Most Bone analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bone stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bone Biologics Corp, talking to its executives and customers, or listening to Bone conference calls.
Bone Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Bone Biologics Corp Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Bone Biologics Corp volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Bone Biologics Corp Trend Analysis
Use this graph to draw trend lines for Bone Biologics Corp. You can use it to identify possible trend reversals for Bone Biologics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Bone Biologics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Bone Biologics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Bone Biologics Corp applied against its price change over selected period. The best fit line has a slop of 0.0092 , which may suggest that Bone Biologics Corp market price will keep on failing further. It has 122 observation points and a regression sum of squares at 3.21, which is the sum of squared deviations for the predicted Bone Biologics price change compared to its average price change.About Bone Biologics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Bone Biologics Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Bone Biologics Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Bone Biologics Corp price pattern first instead of the macroeconomic environment surrounding Bone Biologics Corp. By analyzing Bone Biologics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Bone Biologics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Bone Biologics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Payables Turnover | 0.001341 | 0.001274 | Days Of Inventory On Hand | 368.2 | 327.29 |
Bone Biologics December 1, 2024 Technical Indicators
Most technical analysis of Bone help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Bone from various momentum indicators to cycle indicators. When you analyze Bone charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0489 | |||
| Market Risk Adjusted Performance | 0.7011 | |||
| Mean Deviation | 9.09 | |||
| Semi Deviation | 8.77 | |||
| Downside Deviation | 9.6 | |||
| Coefficient Of Variation | 1944.92 | |||
| Standard Deviation | 19.45 | |||
| Variance | 378.41 | |||
| Information Ratio | 0.0443 | |||
| Jensen Alpha | 0.8074 | |||
| Total Risk Alpha | (2.26) | |||
| Sortino Ratio | 0.0898 | |||
| Treynor Ratio | 0.6911 | |||
| Maximum Drawdown | 163.17 | |||
| Value At Risk | (17.14) | |||
| Potential Upside | 18.13 | |||
| Downside Variance | 92.17 | |||
| Semi Variance | 76.83 | |||
| Expected Short fall | (14.60) | |||
| Skewness | 5.23 | |||
| Kurtosis | 36.65 |
Complementary Tools for Bone Stock analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |